跳至主要内容
临床试验/NL-OMON53396
NL-OMON53396招募中4 期

The effect of low-dose rhythmic 17-β-estradiol administration on bone turnover in postmenopausal women - REBE

Amsterdam UMC0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Postmenopausal, defined as final menstrual cycle more than 12 months prior to
  • inclusion and FSH>30 IU/L
  • - Final menstrual cycle < 10 years prior to inclusion
  • - Age 45-60 years

排除标准

  • Contra-indication for estrogen and/or progesterone therapy: Presence or
  • suspicion or history of breast cancer, endometrial cancer, ovarian cancer,
  • presence or history of venous thromboembolism, arterial thrombosis (e.g.
  • myocardial infarction, angina pectoris) inherited or acquired thrombophilia,
  • presence of liver disease, untreated endometrial hyperplasia, abnormal vaginal
  • bleeding, porphyria, uncontrolled or severe hypertension)
  • First-grade family member with inherited thrombophilia or history of VTE
  • under the age of 60 years
  • Hysterectomy
  • Premature menopause (menopause age <40 years)
  • Known hypersensitivity to the excipients in the estradiol patch: acrylate
  • copolymer, polyethylene terephthalate, a-tocopherol, soy allergy or peanut
  • allergy (component of progesterone capsule)
  • Hormonal contraception or hormone replacement therapy use (estradiol with or
  • without progesterone) in the past 12 months
  • Presence or history of any clinically relevant metabolic, endocrinological,
  • hepatic, renal, cardiovascular, gastrointestinal, or respiratory conditions,
  • history of bone disease or bone marrow disease, known vitamin D deficiency
  • (25-OH vitamin D <30 nmol/L)
  • Recent fracture (<12 months)
  • BMI <20 or BMI >=30
  • Use of drugs including herbal medicine known to affect bone metabolism (e.g.
  • corticosteroids) or to interfere with cytochrome P450 enzyme (CYP) pathways.
  • Exceptions are occasional use of paracetamol, ibuprofen, acetylsalicylic acid
  • or topical medication
  • For adipose tissue biopsy: anticoagulant treatment, allergy to lidocaine

研究者

发起方
Amsterdam UMC

相似试验